Wealthfront Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.12M | Buy |
|
|||||
|
2025
Q2 | $3.94M | Buy |
|
|||||
|
2025
Q1 | $2.35M | Sell |
|
|||||
|
2024
Q4 | $2.97M | Buy |
|
|||||
|
2024
Q3 | $2.28M | Buy |
|
|||||
|
2024
Q2 | $1.97M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Sell |
|
|||||
|
2023
Q4 | $2.22M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Sell |
|
|||||
|
2023
Q2 | $5.25M | Sell |
|
|||||
|
2023
Q1 | $6.87M | Buy |
|
|||||
|
2022
Q4 | $7.74M | Buy |
|
|||||
|
2022
Q3 | $3.68M | Buy |
|
|||||
|
2022
Q2 | $2.06M | Buy |
|
|||||
|
2022
Q1 | $2.1M | Buy |
|
|||||
|
2021
Q4 | $224K | Buy |
|